EMA Authorised: Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) (irbesartan;hydrochlorothiazide) — sanofi-aventis groupe

View source ↗

Summary

EMA authorised Irbesartan Hydrochlorothiazide Zentiva for the treatment of hypertension. The product was previously marketed as Irbesartan/Hydrochlorothiazide W…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Irbesartan Hydrochlorothiazide Zentiva (irbesartan/hydrochlorothiazide)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: sanofi-aventis groupe. Decision date: 16/01/2026